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Summary
Background.— The classic management of neonates with pulmonary atresia with ventricular
septal defect (PAVSD) and moderately hypoplastic pulmonary arteries is usually a systemic to
pulmonary artery shunt or ductus arteriosus stenting. We report our experience of transcatheter
treatment of PAVSD by perforation followed by balloon dilation of the valve, as it is performed
in pulmonary atresia— intact ventricular septum.
Abbreviations: PAVSD, pulmonary atresia with ventricular septal defect; PAIVS, pulmonary atresia with intact ventricular septum.
Abréviations: APSO, atrésie pulmonaire à septum interventriculaire ouvert; APS, Iatrésie pulmonaire à septum interventriculaire
intact.
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Patients and method.— Three patients were treated at a mean age and weight of 7.5 days
(range 7—8) and 2.9 kg (range 2.5—3.3), respectively. Two newborns were prenatally diagnosed,
with micro deletion 22q11 in one case. The three patients had no other pulmonary blood ﬂow
support than the ductus arteriosus and were on prostaglandin E1 infusion. The pulmonary atre-
sia was predominantly valvular without signiﬁcant muscular obstruction. By echocardiography,
the mean size of the pulmonary annulus was 6.5mm (range 6—7). In all cases, the valvular
perforation was performed with a 0.014 coronary guidewire, followed by balloon dilation when
successfully.
Results.— The procedure succeeded in two cases but failed in the third newborn in whom a
long subvalvar muscular stenosis was found at surgery. In the two successful cases, the mean
postprocedural transpulmonary doppler gradient was 33.5mmHg (range 17—50). One patient
experienced a femoral venous thrombosis that was successfully treated by heparin and a tran-
sient right bundle branch block occurred in another one. In the two successful cases, the
prostaglandin E1 infusion was weaned and the surgical repair was performed at 4 and 12months,
respectively.
Conclusion.— In selected cases with PAVSD, perforation followed by balloon dilation of the
pulmonary valve offers an interesting alternative to other surgical or transcatheter palliative
therapies.
© 2009 Elsevier Masson SAS. All rights reserved.
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Résumé
Introduction.— Le traitement de l’atrésie pulmonaire à septum interventriculaire ouvert
(APSO) consiste habituellement en une chirurgie néonatale palliative à type de shunt sys-
témicopulmonaire ou parfois de la mise en place par cathétérisme d’une endoprothèse dans
le canal artériel. La correction complète est réalisée après quelques mois. Nous rappor-
tons notre expérience chez ces patients du cathétérisme néonatal avec perforation puis
valvuloplastie pulmonaire telle qu’elle est pratiquée dans l’atrésie pulmonaire à septum
intact.
Patients et méthode.— Notre recueil rétrospectif depuis janvier 2001 a inclus trois patients
d’âge et de poids moyens de 7,5 jours (7—8) et 2,9 kg (2,5—3,3), respectivement. Tous avaient
une perfusion de prostaglandines E1, sans autre source de ﬂux pulmonaire que le canal artériel.
L’atrésie était principalement valvulaire sans composante musculaire signiﬁcative associée avec
un anneau pulmonaire mesurant en moyenne 6,5mm (6—7). Les perforations valvulaires ont été
effectuées au guide, suivies d’une valvuloplastie au ballonnet.
Résultats.— Le gradient transvalvulaire en ﬁn de procédure était de 33,5mmHg (17—50) chez
deux des patients, la procédure ayant échoué pour le troisième. Lors de sa chirurgie, une
longue sténose musculaire a été retrouvée. Aucune complication n’est survenue en dehors
d’une thrombose veineuse fémorale résolutive et d’un bloc de branche droit transitoire. La
valvuloplastie pulmonaire a permis l’arrêt des prostaglandines E1. La correction chirurgicale a
été réalisée à quatre et 12mois, respectivement.
Conclusion.— La perforation—dilatation par cathétérisme est une alternative intéressante aux
autres traitements néonataux dans certaines APSO. Une plus grande expérience est indispen-
acité et l’innocuité de cette technique.
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ulmonary atresia with ventricular septal defect (PAVSD)
omprises a broad anatomical spectrum as evidenced
y its classiﬁcation in four stages [1]. Therefore, there
re several possible more or less complex manage-
ent approaches depending on the signiﬁcance of lesions
1—4]. The most common approach is the surgical
ystemic to pulmonary artery shunt during the neona-
al period, followed by surgical repair when patients
re a few months older [1,5—8]. In a recent study,
ew cases of PAVSD with valve atresia only, a moder-
tely hypoplastic pulmonary tree, conﬂuent pulmonary
o
c
d
ns droits réservés.
rteries and no aortopulmonary collaterals, have been
reated with perforation followed by valvuloplasty [9].
his technique is similar to that used in the treat-
ent of pulmonary atresia with intact ventricular septum
PAIVS) [10,11] and offers an interesting alternative to
he palliative surgical shunt. Nevertheless, the few cases
eported in a single centre are not enough to demon-
trate the feasibility of this technique [9], insofar as
nly the successful cases are described. Moreover, indi-
ations for this type of catheterization remain poorly
eﬁned.
We report our experience with such management in three
ewborns with PAVSD.
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Patients and method
Patients
From January 2001 to June 2007, three newborns with PAVSD
were treated with perforation followed by pulmonary valvu-
loplasty. The mean age was 7.5 days (range 7—8) and the
mean weight was 2.9 kilograms (range 2.5—3.3). Pulmonary
atresia was purely valvular with a patent infundibulum and
conﬂuent but moderately hypoplastic pulmonary arteries.
There were no aortopulmonary collateral arteries. The duc-
tus arteriosus was the only source of pulmonary blood ﬂow
support in all three cases, maintained with an infusion of
prostaglandin E1.
The mean size of the pulmonary annulus was measured at
6.5mm (range 6—7), while the pulmonary trunk was 6.4mm
(range 6—6.8), the right pulmonary artery was 3.75mm
(range 3.5—4) and the left pulmonary artery was 3.8mm
(range 3.6-4) on the echocardiography.
One of the patients was a carrier of microdeletion 22q11
while the other two had been prenatally diagnosed.
Interventional catheterization
Under general anaesthesia and through femoral vein access,
the initial step consisted in a right ventriculogram on
lateral view, using a right Judkins 2 or 2.5 curve end-
hole coronary catheter (Judkins, Cordis Corporation, NJ,
USA). This angiography performed immediately under the
valve annulus conﬁrmed the pulmonary atresia and its
purely membranous origin (Fig. 1). The 4F right coronary
catheter (Judkins, Cordis Corporation, NJ, USA) is positioned
just below the valve membranous atresia. Two guidewires
Figure 1. Left ventriculogram in left anterior oblique view show-
ing the ductus arteriosus dependence of the pulmonary circulation.
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figure 2. Lateral view angiography in the infundibulum: visual-
sation of Judkins 4F right coronary catheter in contact with the
ulmonary valve atresia.
BMW0,014 Boston Scientiﬁc, Natick, MA, USA) are concomi-
antly inserted in the 4F right coronary catheter, one though
ts rigid tip and the other one through its soft tip. A con-
rast medium injection through a ‘‘Y’’ connection enables
o control the perpendicular positioning of the guidewires
n relation to the valve atresia (Fig. 2). The perforation is
hen performed with the rigid end of the guidewire, which is
dvanced 0.5 cm to 1 cm through the valve annulus (Fig. 3).
he ﬂexible-end guidewire is then positioned in the pul-
igure 3. Lateral view angiogram in the infundibulum during per-
oration of the pulmonary valve by the stiff end of the guidewire.
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sigure 4. Lateral view angiogram in the infundibulum: visu-
lisation of the guidewire in the pulmonary arterial tree after
erforation of the valve.
onary trunk or in the aorta through the ductus arteriosus
y using the rigid end of the other guidewire as a slight
‘rail’’. The wire that was used to perforate the valve is
hen removed and another contrast injection in frontal and
ateral views is performed to check the position of the soft
ip guidewire (Fig. 4). Ballon dilatation of the perforated
alve is then performed (Fig. 5).
esults
n one case, perforation of the pulmonary atresia failed due
o the narrowness and length of the infundibulum which
id not allow correct positioning of the wire. A Blalock-
aussig surgical anastomosis was performed in this patient
few days later. During corrective surgery at 8months, the
nfundibulum was described as hypertrophied and particu-
arly narrow.For the other two cases, the procedure was successful.
he main results are reported in Table 1.
One patient experienced a femoral vein thrombosis,
hich resolved with anticoagulation, and a transitory right
undle branch block was observed following catheterization
9
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Table 1 Characteristics of the two successful pulmonary valv
Pts Balloon (diam)/guidewire Gdt K
1 Tyshaka 6mm/0.014 BMWb 50 123
2 Tyshaka 6mm/0.014 BMWb 17 92
Pts: patients; RBBB: right bundle branch block; diam: diameter; Fem
catheterization; min: minutes; SaO2: transcutaneous oxygen saturation
a Tyshak, NuMed, NY, USA.
b BMW, Boston Scientiﬁc, Natick, MA, USA.igure 5. Lateral view showing pulmonary valvuloplasty with a
mm× 20mm balloon.
n the other one. Infusion with PGE1 could be discontinued
n the two successful cases with closure of the arterial duct
few days after catheterization.
Biventricular surgical repair was successfully performed
t 4months for one patient and 12 for the other. Preoper-
tive catheterization objectiﬁed good development of the
ulmonary arteries (Fig. 6).
After a follow-up of 13 and 21months, neither of these
wo patients needed any additional surgery or interventional
atheterization. The mean hospital length of stay for these
hildren during surgical repair was 10.5 days (range 10—11).
iscussion
ranscatheter perforation of the pulmonary valve using
adiofrequency or with a guidewire had already been widely
escribed for PAIVS in the neonatal period [9—11]. The ﬁrst
ase was reported in 1991 by Qureshi et al. [10]. Since then,
everal retrospective studies conﬁrmed its feasibility in 80 to
0% of cases with failures due to the impossibility of perfo-
ating the valve [10,11]. Our results conﬁrmed its indication
nd feasibility for PAVSD where atresia is purely valvular
nd associated with hypoplasia of the pulmonary arterial
ree. Hence, perforation followed by balloon dilation do
e perforation.
T length (min) Complications SaO2 (%)
Transient RBBB 85
FemV thrombosis 90
: femoral; Gdt: postcatheterization peak-to-peak gradient; KT:
after catheterization and closure of arterial duct; V: vein.
Transcatheter perforation and valvuloplasty in pulmonary atresia
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Interventional catheterization with perforation and dilationFigure 6. Frontal pulmonary angiography at 12months of age
showing good development of the pulmonary arteries before sur-
gical repair.
not lead to congestion due to increased pulmonary blood
ﬂow.
However, PAIVS and PAVSD are very different on an embry-
ological and anatomical standpoint. In PAIVS, the right
ventricle is hypertrophied but the infundibulum is patent
and the pulmonary artery branches are usually well devel-
oped [10,11]. PAVSD on the other hand is a conotruncal heart
disease occurring much sooner in heart development and
due to conal septum malalignment. This anterior and upward
malalignment of the conal septum causes obstruction to
the right ventricular outﬂow tract. This obstruction is more
often valvular and subvalvular, leading to an extreme form of
tetralogy of Fallot [12]. Therefore, the perforation and bal-
loon dilation technique appears to be contraindicated. Only
few reports have been published [2,12—15], with the largest
study including eight cases over a period of six years [14]. In
the case of associated infundibulum narrowing, the proce-
dure was associated with stent implantation [2,13,14]. Our
study suggests that this technique may only apply to PAVSD
with predominantly valvular atresia, conﬂuent but moder-
ately hypoplastic arteries and ductus arteriosus dependant
pulmonary blood ﬂow with no further supply from the aor-
topulmonary collateral arteries.
The diversity in the management of PAVSD reﬂects
the heterogeneous nature of the lesions [3,4]. When the
pulmonary arteries are profoundly hypoplastic with an aor-
topulmonary collateral dependant pulmonary blood ﬂow,
various palliative and curative surgical interventions such
as one stage unifocalization of the pulmonary arterial tree
are performed [4]. When the pulmonary arterial tree is well
developed and dependent on the ductus arteriosus thereby
requiring infusion of prostaglandins E1, there are several
therapeutic options. Rarely, surgical correction is performed
in the newborn [16]. In the majority of the centres, an initial
palliative step is performed in the neonate followed by cor-
o
o
e
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ective surgery 4 to 12months later. This palliation may be
urgical with a modiﬁed Blalock-Taussig anastomosis, which
ay be complicated by distortion of the pulmonary arteries,
articularly if they are hypoplastic [3,5,6,17]. It may also
nclude interventional catheterization with stent implanta-
ion in the arterial duct. Nevertheless, the latter is often
echnically difﬁcult in PAVSD that is readily associated with a
ortuous arterial duct [18]. In addition, the pulmonary blood
ow is provided in an asymmetrical and partially retrograde
irection, that is less favourable to pulmonary artery growth
han an anterograde ﬂow [19].
Historically, this perforation followed by balloon dilation
trategy is inspired by dilation of the pulmonary valve in
he tetralogy of Fallot suggested about twenty years ago.
hile this remains a controversial procedure, encourag-
ng results have been published. Yet, indications for such
rocedure remain limited as this technique concerned the
are patients with a predominantly valvular obstruction.
oreover, the development of successful surgical repair for
etralogy of Fallot earlier in life further limit the indi-
ations for balloon dilation of the pulmonary valve [20].
imilarly to balloon dilation, perforation followed by pul-
onary valvuloplasty is an interesting alternative in rare
ases of PAVSD with moderately hypoplastic but conﬂuent
ulmonary arteries, since an anterograde and pulsatile ﬂow
ffers a better growth potential for the pulmonary arteries
2,12—14]. The induced pulmonary insufﬁciency also con-
ributes to their development. In addition, this treatment
nables an easier access to the pulmonary arterial tree if
urther diagnostic or interventional catheterization is indi-
ated, for example, in the case of branch pulmonary stenosis
14]. Finally, surgical repair is performed at an age when its
orbidity and mortality are lower [2,12—14]. The assess-
ent and extensive use of this technique are restricted by
he low number of patients concerned. Moreover, the expe-
ience reported on the perforation of PAIVS revealed that
omplications occur in approximately 15% of cases, while
he most common and dangerous include cardiac perforation
esponsible for rare deaths [10,11]. During the perfora-
ion procedure, the wire may perforate the infundibulum,
hich most often does not lead to major pericardial effusion
13,14]. However, in the Canadian study, the percentage of
ight ventricular perforation was close to 50% with haemo-
ynamic instability in one patient [14]. In this setting, the
se of biplane system enabling to visualise the perforation
hrough frontal and lateral plan is mandatory. In addition,
he use of radiofrequency instead of the stiff tip of a
uidewire could decrease the rate of perforation. Finally,
ascular complications including femoral thrombosis, blood
oss with the need blood transfusions are potentially more
ommon in newborns. All this reinforces the concept that
his type of interventional catheterization should only be
ractised by very experienced teams.
onclusionf the pulmonary valve offers an interesting alternative to
ther palliative therapies for some cases of PAVSD with mod-
rately hypoplastic but conﬂuent pulmonary arteries and
patent infundibulum. It only applies to a small number
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f patients. Its indication should be discussed according to
ndividual cases and in relation to the beneﬁt/risk ratio com-
ared with surgery, which remains the reference method. In
ll cases, it must be performed by an experienced team.
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